DEER PARK, Ill., Aug. 23, 2023 Eton Pharmaceuticals, Inc , an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that Sean.
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 5,800 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $17.05 per share, with a total value of $98,890.00. Following the completion of the transaction, the chief executive […]
Harrow Health, Inc. (NASDAQ:HROW) Director Buys $338,400.00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s stock price gapped up before the market opened on Tuesday following insider buying activity. The stock had previously closed at $17.28, but opened at $17.64. Harrow Health shares last traded at $17.73, with a volume of 81,425 shares trading hands. Specifically, CEO Mark L. Baum acquired 5,800 […]
Harrow Health (NASDAQ:HROW – Free Report) had its price objective upped by LADENBURG THALM/SH SH from $33.70 to $34.40 in a report published on Thursday morning, FlyOnTheWall reports. HROW has been the subject of a number of other research reports. B. Riley upped their price target on Harrow Health from $42.00 to $45.00 and gave […]